Lucid Diagnostics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LUCD and other ETFs, options, and stocks.About LUCD
Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma.
LUCD Key Statistics
Stock Snapshot
The current Lucid Diagnostics(LUCD) stock price is $1.17, with a market capitalization of 233.53M. The stock trades at a price-to-earnings (P/E) ratio of -2.13.
On 2026-07-15, Lucid Diagnostics(LUCD) stock moved within a range of $1.00 to $1.23. With shares now at $1.17, the stock is trading +17.0% above its intraday low and -4.5% below the session's peak.
Trading volume for Lucid Diagnostics(LUCD) stock has reached 5.17M, versus its average volume of 1.15M.
Over the past 52 weeks, Lucid Diagnostics(LUCD) stock has traded between a high of $1.63 and a low of $0.90.
Over the past 52 weeks, Lucid Diagnostics(LUCD) stock has traded between a high of $1.63 and a low of $0.90.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.